Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials

被引：0
|
作者：
Kitley, J. [1 ]
Leite, M. I. [1 ]
Elsone, L. [2 ]
Jacob, A. [2 ]
Palace, J. [1 ]
机构：
[1] John Radcliffe Hosp, Oxford OX3 9DU, England
[2] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [41] Vitamin D Level may be Associated with The Relapse Free Time in Neuromyelitis Optica Spectrum Disorder.
    Lee, Hye Lim
    Min, Ju-Hong
    Cho, Eun Bin
    Seok, Jin Myoung
    Cho, Hye-Jin
    Lee, Kwang Ho
    Kim, Byoung Joon
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 428 - 428
  • [42] Clinical predictors of the relapsing form of neuromyelitis optica and the time to subsequent respiratory failure
    Wingerchuk, DM
    Weinshenker, BG
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (03) : S55 - S55
  • [43] A new primary efficacy endpoint for specific immunotherapy clinical trials
    Vicaut, E.
    Grouin, J.
    Devillier, P.
    de Beaumont, O.
    Montagut, A.
    Le Gall, M.
    Jean-Alphonse, S.
    [J]. ALLERGY, 2009, 64 : 466 - 466
  • [44] Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort Demographic, Clinical, and Laboratory Features
    Altintas, Ayse
    Karabudak, Rana
    Balci, Belgin P.
    Terzi, Murat
    Soysal, Aysun
    Saip, Sabahattin
    Kurne, Asli Tuncer
    Uygunoglu, Ugur
    Nalbantoglu, Mecbure
    Celik, Gokcen Gozubatik
    Isik, Nihal
    Celik, Yahya
    Gokcay, Figen
    Duman, Taskin
    Boz, Cavit
    Yucesan, Canan
    Mangan, Mehmet Serhat
    Celebisoy, Nese
    Diker, Sevda
    Isikay, Ilksen Colpak
    Kansu, Tulay
    Siva, Aksel
    [J]. NEUROLOGIST, 2015, 20 (04) : 61 - 66
  • [45] Long-term corticosteroid administration prevents relapse in neuromyelitis optica
    Watanabe, S.
    Misu, T.
    Fujihara, K.
    Nakashima, I.
    Miyazawa, I.
    Shiga, Y.
    Itoyama, Y.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S104 - S104
  • [46] Factors associated with disease relapse rate in the Neuromyelitis optica spectrum disorder
    Li, Hai-yun
    Cui, Cai-san
    Yang, Hui-min
    Jiang, Wen-jing
    Yang, Xiang-dong
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (10) : 1114 - 1119
  • [47] Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapse
    Farber, Rebecca Straus
    Gross, Robert
    Zakin, Elina
    Fabian, Michelle
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (07) : 988 - 994
  • [48] Neuromyelitis optica: clinical features, immunopathogenesis and treatment
    Jarius, S.
    Wildemann, B.
    Paul, F.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (02): : 149 - 164
  • [49] Real time monitoring and prediction of time to endpoint maturation in clinical trials
    Wang, Li
    Liu, Yang
    Chen, Xiaotian
    Pulkstenis, Erik
    [J]. STATISTICS IN MEDICINE, 2022, 41 (18) : 3596 - 3611
  • [50] Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder
    Sechi, Elia
    Parks, Natalie E.
    Koeller, Kelly K.
    Flanagan, Eoin P.
    [J]. NEUROLOGY, 2019, 92 (07) : 343 - 344
12345